Abbott LaboratoriesvsHaemonetics

ABT and HAE stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$107.45

Value $187B

-0.99%
ABT's page

HAE

Haemonetics Corporation

$121.34

Value $5.5B

-1.30%
HAE's page

Abbott Laboratories (ABT) has a market value of $187B and Haemonetics (HAE) $5.5B. Over the last year, with dividends, ABT moved -15.7% and HAE +65.1%. The P/E is 39.7 for ABT and 53.1 for HAE. Dividend yield: ABT 2.35%, HAE none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$187B

    HAE$5.5B

    ABT is 34 times HAE

  • Revenue, 12 months

    ABT$48.2B

    HAE$1.4B

    ABT is 35 times HAE

  • Net income, 12 months

    ABT$4.7B

    HAE$104M

    ABT is 45 times HAE

  • Operating margin

    ABT13.8%

    HAE12.8%

    1.0 points apart

  • ROIC

    ABT6.3%

    HAE6.3%

    About the same

  • P/E

    ABT39.7

    HAE53.1

    HAE is 1.3 times ABT

  • Dividend yield

    ABT2.4%

    HAE0.0%

    2.4 points apart

  • 5-year return

    ABT-8.3%

    HAE+109.6%

    117.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-8.3%

HAE+109.6%

10015020020222023202420252026
Returns by period
PeriodABTWith dividendsHAEWith dividends
1 year since November 14, 2025-15.7%Price -17.7%+65.1%Price +65.1%
3 years since November 16, 2023+14.2%+4.5% a yearPrice +7.2%+36.0%+10.8% a yearPrice +36.0%
5 years since November 15, 2021-8.3%-1.7% a yearPrice -17.0%+109.6%+15.9% a yearPrice +109.6%
10 years since November 16, 2016+224.5%+12.5% a yearPrice +169.0%+209.1%+11.9% a yearPrice +209.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesHAEHaemonetics

Valuation

ABTHAE
Valuation
Price$107.45$121.34
Market value$187B$5.5B
Enterprise value (EV)$214B$6.4B
P/E39.753.1
P/E, 5-year median33.736.9
P/B3.76.1
EV/EBIT32.136.0
Free cash flow yield3.6%5.4%

Results and growth

ABTHAE
Results and growth
Revenue, 12 months$48.2B$1.4B
Net income, 12 months$4.7B$104M
Free cash flow, 12 months$6.8B$298M
Earnings per share, 12 months$2.69$2.26
Revenue growth, year on year5.7%-2.0%
Revenue growth a year, past+5.1%over 5 years+8.9%over 5 years
EPS growth a year, past+8.3%over 5 years+5.8%over 5 years

Margins and returns on capital

ABTHAE
Margins and returns on capital
Gross margin56.9%59.6%
Operating margin13.8%12.8%
Net margin9.8%7.5%
ROIC6.3%6.3%
ROE9.1%12.1%

Balance sheet

ABTHAE
Balance sheet
Cash$4.3B$261M
Total debt$31.2B$1.1B
Net debt / EBITDA3.33.0
Interest cover6.7×9.2×

Dividends and buybacks

ABTHAE
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%3.2%
Shareholder yield2.8%3.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or HAE

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Haemonetics?

By market value, Abbott Laboratories ($187B) is about 33.9 times Haemonetics ($5.5B), at today's prices.

How did ABT and HAE stock do over the last 10 years?

Since November 16, 2016, ABT's price moved +169.0% and HAE's +209.1%. With dividends: ABT +224.5% (+12.5% a year), HAE +209.1% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or HAE?

The dividend yield at today's price is 2.35% for Abbott Laboratories and none for Haemonetics. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and HAE?

At today's price, the P/E is 39.7 for ABT and 53.1 for HAE. The median of the last five years was 33.7 and 36.9, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or Haemonetics?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 7.5% for Haemonetics, and the operating margin 13.8% and 12.8%. Revenue was $48.2B and $1.4B.

Which is the better investment, Abbott Laboratories or Haemonetics?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.